Substance / Medication

Albendazole

Overview

Active Ingredient
albendazole
RxNorm CUI
430
Labeler: Golden State Medical Supply, Inc.Updated: 2026-01-08T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Albendazole Tablets are contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of Albendazole Tablets.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
3
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of albendazole against soil-transmitted helminth infections in Ethiopia: a systematic review and meta-analysis.
Sisay Miseganaw, Damtie Destaw, Hailu Tadesse · Sci Rep · 2024
PMID: 39304661Meta-AnalysisFull text (PMC)
Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis.
Whittaker Charles, Chesnais Cédric B, Pion Sébastien D S et al. · PLoS Negl Trop Dis · 2022
PMID: 36306320Meta-AnalysisFull text (PMC)
Environmental risk assessment of the anthelmintic albendazole in Eastern Africa, based on a systematic review.
Belew Sileshi, Suleman Sultan, Wynendaele Evelien et al. · Environ Pollut · 2021
PMID: 33272795Meta-Analysis
Albendazole-Induced Liver Injury.
Piloiu Claudia, Dumitrascu Dan L · Am J Ther · 2021
PMID: 33590990Meta-Analysis
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Macfarlane Cara L, Budhathoki Shyam S, Johnson Samuel et al. · Cochrane Database Syst Rev · 2019
PMID: 30620051Meta-AnalysisFull text (PMC)
Anal Albendazole application for pruritus ani in threadworm infestation.
Singh Shivaram Prasad, Panda Chittaranjan, Rout Niranjan et al. · J Trop Pediatr · 2005
PMID: 15958409RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Albendazole (substance)
SNOMED CT
387558006
UMLS CUI
C0001911
RxNorm CUI
430
Labeler
Golden State Medical Supply, Inc.

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

13
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.